HC
ABBV icon

Hurley Capital’s AbbVie ABBV Stock Holding History

Hurley Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218K Buy
866
+112
+15% +$24.1K 0.11% 90
2026
Q1 		$164K Buy
754
+52
+7% +$11.5K 0.09% 96
2025
Q4 		$160K Buy
702
+18
+3% +$4.1K 0.09% 92
2025
Q3 		$158K Sell
684
-86
-11% -$17.5K 0.09% 104
2025
Q2 		$143K Buy
770
+8
+1% +$1.49K 0.1% 89
2025
Q1 		$160K Buy
762
+6
+0.8% +$1.17K 0.12% 92
2024
Q4 		$139K Buy
+756
New +$139K 0.11% 87

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hurley Capital's ABBV Position: Q2 2026 in Review

Hurley Capital increased its AbbVie (ABBV) stake by 15% in Q2 2026, buying an estimated $24.1K and bringing the position to 866 shares worth $218K. The position accounts for 0.11% of the portfolio, ranked #90.

Hurley Capital first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Hurley Capital held 866 shares of AbbVie worth $218K as of Q2 2026.
  • Hurley Capital bought 112 AbbVie shares in Q2 2026, an estimated $24.1K.
  • AbbVie made up 0.11% of Hurley Capital's portfolio in Q2 2026, its #90 holding.
  • Hurley Capital first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Hurley Capital's 13F filing for Q2 2026, filed 10 Aug 2026.